Pharmacokinetic/Pharmacodynamic (PK/PD) Study Evaluating DA-3031 (PEG-G-CSF) to Filgrastim (Dong-A) in Healthy Volunteers
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The safety, tolerability, and pharmacokinetics(PK)/pharmacodynamics (PD) of DA-3031
(PEG-G-CSF) following a single dose delivered by subcutaneous (SC) injection were
investigated in healthy volunteers. PK/PD of filgrastim (Dong-A) following repeated dose
delivered by SC injection were investigated in healthy volunteers. PK/PD from a single dose
of DA-3031 and repeated dose of filgrastim (Dong-A) were compared.